WEX — Feb 5, 2025 release

The following table presents cash spent on share buybacks and ending undiluted shares outstanding for each of the preceding quarters: (In millions, except per share amounts) For the three months ended 6/30/22 9/30/22 12/31/22 3/31/23 6/30/23 9/30/23 12/31/23 3/31/24 6/30/24 9/30/24 13 12/31/2024 10 Cash Spent Repurchasing Shares $ 80.6  $ 69.0  $ 141.2  $ 92.2  $ 3.2  $ 50.0  $ 150.0  $ 73.6  $ 100.0  $ 370.0  $ 106.0   Cumulative Cash Spent $ 149.6  $ 290.8  $ 383.0  $ 386.1  $ 436.1  $ 586.2  $ 659.8  $ 759.8  $ 1,129.8  $ 1,235.8   Share Repurchased 0.52  0.43  0.95  0.53  0.02  0.26  0.87  0.35  0.47  1.72  0.77   Cumulative Shares Repurchased 0.95  1.90  2.43  2.45  2.71  3.58  3.93  4.39  6.12  6.89   Share repurchases accounted for the largest share of our capital deployment in 2024, totaling approximately $650 million and underscoring our commitment to returning value to shareholders. To support this commitment, our Board of Directors increased the share repurchase program authorization by $1 billion in September 2024, expanding the total authorization to $2.05 billion from the previous $1.05 billion through December 31, 2025. $964 million remains in our authorization as of the end of Q4 2024. Since our share count was last below 40 million in 2016, we have achieved approximately 200% revenue growth and more than 500% growth in adjusted net income. (12)      This line is presented on a cash basis and includes all consideration transferred in the related quarter, including deferred and contingent payments when they are paid as opposed to when the underlying transaction occurred. (13)      During the third quarter of 2024, we entered into an ASR agreement with JPMorgan to repurchase an aggregate of $300.0 million of the Company’s outstanding common stock. Under the ASR, the Company made a payment of $300.0 million to JPMorgan for which we received an initial delivery of approximately 1.3 million shares of our common stock. For purposes of this table, we have included the full payment amount and the initial delivery of shares in the quarter ended September 30, 2024. During the fourth quarter of 2024, the ASR was settled resulting in the receipt of an additional 0.2 million shares of WEX common stock, which is included in the quarter ended December